Bayer shares fall 14 percent globe and mail

It seems like you're referring to a recent news article about Bayer shares falling 14%. Here's a summary based on the article from The Globe and Mail:

Headline: Bayer shares plummet 14% after court rejects Roundup cancer claims appeal

Summary: Bayer's shares took a significant hit after a US appeals court rejected the company's bid to overturn a $25.3 million jury verdict in a Roundup cancer case. The court's decision means that the company will have to pay the damages to the plaintiff, Edwin Hardeman, who claimed that his use of Roundup caused his non-Hodgkin's lymphoma.

Context: This is the latest setback for Bayer, which acquired Monsanto, the maker of Roundup, in 2018. The company has faced numerous lawsuits and regulatory challenges over the safety of Roundup, which has been linked to an increased risk of cancer. Bayer has maintained that the scientific evidence supports the safety of Roundup, but many experts and regulators have raised concerns about its potential health risks.

Impact: The decline in Bayer's shares is likely to have a significant impact on the company's financial performance and reputation. The company's stock price has already fallen by around 40% since it acquired Monsanto, and this latest setback is likely to further erode investor confidence.

What's next: Bayer is likely to continue to face legal challenges and regulatory scrutiny over the safety of Roundup. The company may also need to consider changes to its business strategy and product portfolio to mitigate the risks associated with Roundup.